help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/endo-87-6-1119
Endocrinology Vol. 87, No. 6 1119-1123
Copyright © 1970 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KORENMAN, S. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by KORENMAN, S. G.

Relation Between Estrogen Inhibitory Activity and Binding to Cytosol of Rabbit and Human Uterus

STANLEY G. KORENMAN1

Department of Medicine, Harbor General Hospital Campus, UCLA School of Medicine Torrance, California 90509

Abstract

The ability of a group of nonsteroidal antiestrogens to compete with tritiated 17β-estradiol (E2) for binding sites in the cytoplasm of rabbit and human uterus was tested in vitro.The mean relative activities (RA) and ratios of equilibrium constants of association (RAC) compa ed to E2 were much higher for the 2 stilbene derivatives, erythro-MEA and dimethylstilbestrol, than for CN-55-945-27, cisclomiphene, trans-clomiphene, U-11-555A and MER-25. In both species, cis clomiphene was much more active than trans-clomiphene. The RAC's of the non-stilbene derivatives resembled their estrogenic potencies, as found in the literature. Reports of antiestrogenic potencies were extremely variable but were frequently as low as or lower than the RAC. The datasuggest that all these inhibitors are weak estrogens competing effectively for uterine receptors when in high concentration, but rapidly lost from the target organ as a result of their low association constants for the specific binding site. (Endocrinology 87: 1119, 1970)

Footnotes

1 Present address: Department of Internal Medicine, University of Iowa, Iowa City, Iowa 52240.

Received December 23, 1969.




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
M. Melamed, E. Castaño, A. C. Notides, and S. Sasson
Molecular and Kinetic Basis for the Mixed Agonist/Antagonist Activity of Estriol
Mol. Endocrinol., November 1, 1997; 11(12): 1868 - 1878.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. M. Rink, K. J. Yarema, M. S. Solomon, L. A. Paige, B. M. Tadayoni-Rebek, J. M. Essigmann, and R. G. Croy
Synthesis and biological activity of DNA damaging agents that form decoy binding sites for the estrogen receptor
PNAS, December 24, 1996; 93(26): 15063 - 15068.
[Abstract] [Full Text] [PDF]


Home page
JDRHome page
W.F. Liljemark and S.V. Schauer
Competitive Binding Among Oral Streptococci to Hydroxyapatite
Journal of Dental Research, February 1, 1977; 56(2): 157 - 165.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1970 by The Endocrine Society